Corneagen, Inc.
CorneaGen is dedicated to transforming how ophthalmologists treat and care for every person impacted by corneal disease through high-quality donor tissue, innovative products, and industry partnerships. With a mission to eliminate corneal blindness, they lead research efforts, develop new technologies, and provide unparalleled service and products to improve patient outcomes worldwide.
Industries
Nr. of Employees
medium (51-250)
Corneagen, Inc.
1200 6th Ave., Ste. 300, Seattle, WA 98101
Patents
Systems and methods for separating tissue in corneal transplant procedures
US-11730508-B2
View Details
Systems and methods for separating tissue in corneal transplant procedures
US-11730508-B2
View DetailsProducts
Patient‑specific sterile corneal tissue segments
Laser‑cut, gamma‑irradiated corneal tissue segments produced to match patient anatomy for corneal contouring procedures.
Pre‑loaded delivery systems for endothelial and lamellar grafts
Instruments and pre‑loaded delivery devices provided with endothelial or lamellar grafts to facilitate implantation and minimize graft handling.
Sterile grafts and ocular tissue portfolio
A portfolio of surgical tissue preparations for corneal and ocular surgery, including posterior lamellar, penetrating grafts and scleral tissue preparations.
Patient‑specific sterile corneal tissue segments
Laser‑cut, gamma‑irradiated corneal tissue segments produced to match patient anatomy for corneal contouring procedures.
Pre‑loaded delivery systems for endothelial and lamellar grafts
Instruments and pre‑loaded delivery devices provided with endothelial or lamellar grafts to facilitate implantation and minimize graft handling.
Sterile grafts and ocular tissue portfolio
A portfolio of surgical tissue preparations for corneal and ocular surgery, including posterior lamellar, penetrating grafts and scleral tissue preparations.
Services
Recovery, processing and distribution of donor corneal tissue prepared in multiple surgical configurations to support ophthalmic procedures.
Manufacture and supply of gamma‑irradiated sterile corneal tissue segments with patient‑specific customization for corneal contouring and related procedures.
Live and recorded educational programs including wet labs, webinars and surgical technique videos to support surgeon training and procedure adoption.
Consultative analysis and documentation to assist providers with reimbursement and payer billing practices for surgical tissue products.
Centralized adverse reaction reporting forms and QA/regulatory contacts to manage recipient complications and maintain compliance with tissue safety requirements.
Recovery, processing and distribution of donor corneal tissue prepared in multiple surgical configurations to support ophthalmic procedures.
Manufacture and supply of gamma‑irradiated sterile corneal tissue segments with patient‑specific customization for corneal contouring and related procedures.
Live and recorded educational programs including wet labs, webinars and surgical technique videos to support surgeon training and procedure adoption.
Consultative analysis and documentation to assist providers with reimbursement and payer billing practices for surgical tissue products.
Centralized adverse reaction reporting forms and QA/regulatory contacts to manage recipient complications and maintain compliance with tissue safety requirements.
Expertise Areas
- Corneal tissue processing and eye‑bank services
- Sterile graft manufacturing and preservation
- Surgical delivery system development for corneal procedures
- Clinical training and surgeon education
Key Technologies
- Gamma irradiation sterilization
- Laser-based tissue cutting
- Pre‑loaded surgical delivery devices
- Sterile tissue preservation and long‑term storage
News & Updates
A message from Bernie Iliakis, President & CEO, sharing recent company highlights and industry insights.
Update from Bernie Iliakis on company progress, partnerships, and industry developments.
Announcement of the new corneal tissue addition solution for keratoplasty, highlighting its benefits and surgeon feedback.
Summary of the company's achievements in 2023, including record tissue provision and global partnerships.
Details about the company's recognition for employee wellness and commitment to health.
Details about the new product launch aimed at improving outcomes for keratoconus patients.
A message from Bernie Iliakis, President & CEO, sharing recent company highlights and industry insights.
Update from Bernie Iliakis on company progress, partnerships, and industry developments.
Announcement of the new corneal tissue addition solution for keratoplasty, highlighting its benefits and surgeon feedback.
Summary of the company's achievements in 2023, including record tissue provision and global partnerships.
Details about the company's recognition for employee wellness and commitment to health.
Details about the new product launch aimed at improving outcomes for keratoconus patients.